Forward Dough Ventures

www.forwardventures.com

VCMatch tracks Forward Dough Ventures as an investor focused on Biotech and Pharma companies, Pre-Seed and Seed rounds, and United States, San Diego, and Global markets. Upload your deck to compare your startup against the full private matching profile.

Check Size

Not specified

Stages

Pre-Seed, Seed, Series A, Series B, Series C, Growth, Late Stage

Focus Areas

Biotech, Pharma

Geography

United States, San Diego, and Global

Investment Thesis

Forward Ventures pursues durable, capital-efficient value creation in life sciences by partnering closely with entrepreneurs to build companies that develop and commercialize innovative therapies addressing unmet medical needs. The firm leverages nearly three decades of venture experience, scientific and operational expertise, and hands-on board and management support—including seeding companies from scratch—to maximize returns for limited partners while pursuing cures for serious diseases.

Is Forward Dough Ventures right for your startup?

Upload your pitch deck to compare your startup against VCMatch's private investor profile, including fit, timing, and next-step signals.

See If You're a Match View Sample Match

Investment Focus

Who should take a closer look

Forward Dough Ventures is most relevant for founders raising Pre-Seed, Seed, and Series A rounds in Biotech and Pharma, especially across United States, San Diego, and Global.

Focus statement

Forward Ventures' stated primary focus is "biopharmaceutical therapeutics," investing "in all stages of company development" with its most recent fund focused on "biopharmaceutical products in early clinical development."

Value Add

Long track record: "Over nearly 30 years, Forward Ventures has founded, financed, and developed more than 60 life science companies."
Hands-on, operationally experienced team: "The firm's extensive scientific and business networks and hands-on team approach have added significant value to our portfolio companies."
Board leadership and active portfolio involvement: "The partners take leadership positions on the Board of their portfolio companies."
Capital-efficiency orientation: "We maximize returns through capital efficiency in our portfolio companies." and "To be capital efficient, we deploy capital in a disciplined manner often tranched to clearly defined milestones."
Ability to seed and build companies from scratch: "On a number of occasions, we have seeded companies from scratch, building strong teams to pursue compelling opportunities."
Geographic and sourcing reach: headquartered in San Diego ("an elite biomedical research and innovation community") but "sourced assets and technologies globally" (example: "Tioga Pharmaceuticals is based on a drug developed in Germany and licensed to a new company founded by Forward Ventures").
Cross-border/Asia capabilities: dedicated effort to a cross-border program involving Asia/China led by senior team members.